Detect AF Study²

First study to evaluate performance of the Confirm Rx ICM predecessor DM2102 ICM to detect atrial fibrillation (AF) published in the Journal of Cardiovascular Electrophysiology in September 2016:

1. The 90-patient study that compared the DM2102 ICM to a Holter monitor found:
   1. DM2102 ICM can accurately detect AF episodes at least two minutes in length.
   2. DM2102 ICM had a 94% AF episode sensitivity and a 93.7% Postitive Predictive Value (PPV).                                                                        
2. The positive finding shows value of Abbott technology to detect AF.
   

    This device is commercially available for use in select international markets.

References

1. Ip J, Jaffe B, Castellani M, et al. Arrhythmia Detection in Implantable Cardiac Monitor Randomized Clinical Trial Comparing Reveal LINQ‡ and Confirm Rx. PACE. Sept. 24, 2020. https://doi.org/10.1111/pace.14076
2. Nölker G, Mayer J, Boldt L, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. Journal of Cardiovascular Electrophysiology. 2016;27(12):1403-1410. doi:10.1111/jce.13089

™ Indicates a trademark of the Abbott group of companies.

^‡ Indicates a third-party trademark, which is property of its respective owner.